Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of GBP 9.91 billion. The enterprise value is 9.99 billion.

Market Cap	9.91B
Enterprise Value	9.99B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	182.14M
Shares Outstanding	n/a
Shares Change (YoY)	+20.00%
Shares Change (QoQ)	+1.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	165.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.62
PB Ratio	129.17
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.74
EV / Sales	35.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.36

Financial Position

The company has a current ratio of 5.86, with a Debt / Equity ratio of 13.17.

Current Ratio	5.86
Quick Ratio	5.21
Debt / Equity	13.17
Debt / EBITDA	n/a
Debt / FCF	-1.65
Interest Coverage	-9.76

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-36.25%
Return on Invested Capital (ROIC)	-46.53%
Return on Capital Employed (ROCE)	-54.94%
Revenue Per Employee	232,033
Profits Per Employee	-617,039
Employee Count	1,271
Asset Turnover	0.26
Inventory Turnover	0.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.68% in the last 52 weeks. The beta is 0.79, so Insmed's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+28.68%
50-Day Moving Average	69.92
200-Day Moving Average	73.11
Relative Strength Index (RSI)	61.89
Average Volume (20 Days)	371

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.23

Income Statement

In the last 12 months, Insmed had revenue of GBP 294.91 million and -784.26 million in losses. Loss per share was -4.56.

Revenue	294.91M
Gross Profit	225.59M
Operating Income	-664.86M
Pretax Income	-781.14M
Net Income	-784.26M
EBITDA	-657.76M
EBIT	-664.86M
Loss Per Share	-4.56

Full Income Statement

Balance Sheet

The company has 928.36 million in cash and 1.01 billion in debt, giving a net cash position of -82.38 million.

Cash & Cash Equivalents	928.36M
Total Debt	1.01B
Net Cash	-82.38M
Net Cash Per Share	n/a
Equity (Book Value)	76.75M
Book Value Per Share	0.42
Working Capital	900.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -589.73 million and capital expenditures -21.14 million, giving a free cash flow of -610.87 million.

Operating Cash Flow	-589.73M
Capital Expenditures	-21.14M
Free Cash Flow	-610.87M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.49%, with operating and profit margins of -225.44% and -265.93%.

Gross Margin	76.49%
Operating Margin	-225.44%
Pretax Margin	-264.87%
Profit Margin	-265.93%
EBITDA Margin	-223.04%
EBIT Margin	-225.44%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.00%
Shareholder Yield	n/a
Earnings Yield	-7.91%
FCF Yield	-6.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Insmed has an Altman Z-Score of -0.23. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.23
Piotroski F-Score	n/a